Ethyl 1-benzyl-2-(4-methylphenyl)-1h-pyrrolo[2,3-b]quinoxaline- 3-carboxylate và ethyl 6,7-dimethyl-1,2- diphenyl-1h-pyrrolo[2,3-b]quinoxaline-3-carboxylate: tổng hợp và phân tích phổ cộng hưởng từ hạt nhân
Tóm tắt: 155
|
PDF: 146
##plugins.themes.academic_pro.article.main##
Author
-
Vo Viet DaiThe University of Danang - University of Science and Education, VietnamBui Bich LocThe University of Danang - University of Science and Education, VietnamNguyen Tran NguyenThe University of Danang - University of Science and Education, Vietnam
Từ khóa:
Tóm tắt
Nhiều dẫn xuất pyrrolo[2,3-b]quinoxaline đã được tổng hợp và qua khảo sát cho thấy chúng có hoạt tính sinh học, dược động học có giá trị. Tuy nhiên, các phương pháp sử dụng xúc tác kim loại nặng trong quá trình tổng hợp đã làm hạn chế việc ứng dụng các phương pháp này trong công nghiệp hoá dược. Trong nghiên cứu này, hai dẫn xuất pyrrolo[2,3-b]quinoxaline đã được tổng hợp thông qua phản ứng cộng nucleophile giữa hai dẫn xuất 1,5-disubstituted-4-ethoxycarbonyl-3-hydroxy-3-pyrroline-2-one và tác nhân nucleophile là o-phenylenediamine hoặc 4,5-dimethyl-o-phenylenediamine trong dung môi acetic acid khan. Trong môi trường acid của acetic acid, các hợp chất 1,5-disubstituted-4-ethoxycarbonyl-3-hydroxy-3-pyrroline-2-one có thể bị tautomer hoá thành dạng keto, còn được gọi là các dẫn xuất 2,3-dioxopyrrolidine. Ngoài ra, cấu trúc của hai dẫn xuất pyrrolo[2,3-b]quinoxaline cũng đã được phân tích và chứng minh dựa vào phổ cộng hưởng từ hạt nhân và phổ khối phân giải cao.
Tài liệu tham khảo
-
[1] A. Pereira et al., “Quinoxaline, its derivatives and applications: A State of the Art review”, European Journal of Medicinal Chemistry, vol. 97, no. 5, pp. 664-672, 2015. https://doi.org/10.1016/j.ejmech.2014.06.058
[2] Montana, F. Mathias, T. Terme, and P. Vanelle, “Antitumoral activity of quinoxaline derivatives: A systematic review”, European journal of medicinal chemistry, vol. 163, no. 1, pp. 136-147, 2019. https://doi.org/10.1016/j.ejmech.2018.11.059
[3] -H. Xia et al., “Design, synthesis, biological evaluation and molecular docking study on peptidomimetic analogues of XK469”, European journal of medicinal chemistry, vol. 124, no. 29, pp. 311-325, 2016. https://doi.org/10.1016/j.ejmech.2016.08.010
[4] Unzue, J. Dong, K. Lafleur, H. Zhao, E. Frugier, A. Caflisch, and C. Nevado, “Pyrrolo [3,2-b] quinoxaline derivatives as types I1/2 and II Eph tyrosine kinase inhibitors: structure-based design, synthesis, and in vivo validation”, Journal of medicinal chemistry, vol. 57, no. 15, pp. 6834-6844, 2014. https://doi.org/10.1021/jm5009242
[5] Guillon et al., “Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2”, European Journal of Medicinal Chemistry, vol. 65, pp. 205-222, 2014. https://doi.org/10.1016/j.ejmech.2013.04.051
[6] Sakata, K. Makino, and Y. Kurasawa, “Regent progress in the quinoxaline chemistry. synthesis and biological activity”, Heterocycles, vol. 27, no. 10, pp. 2481-2515, 1988.
[7] -Y. Jaung, “Synthesis and halochromism of new quinoxaline fluorescent dyes”, Dyes and Pigments, vol. 71, no. 3, pp. 245-250, 2006. https://doi.org/10.1016/j.dyepig.2005.07.008
[8] R. J. Thomas, M. Velusamy, J. T. Lin, C. -H. Chuen, and Y. -T. Tao, “Chromophore-labeled quinoxaline derivatives as efficient electroluminescent materials”, Chemistry of Materials, vol. 17, no. 7, pp. 1860-1866, 2005. https://doi.org/10.1021/cm047705a
[9] O’Brien, M. S. Weaver, D. G. Lidzey, and D. D. C. Bradley, “Use of poly(phenyl quinoxaline) as an electron transport material in polymer light‐emitting diodes”, Applied Physics Letter, vol. 69, no. 7, pp. 881-883, 1996. https://doi.org/10.1063/1.117975
[10] Prasad et al., “AlCl3 induced C–N bond formation followed by Pd/C–Cu mediated coupling–cyclization strategy: synthesis of pyrrolo[2,3-b]quinoxalines as anticancer agents”, Tetrahedron Letters, vol. 53, no. 45, pp. 6059-6066, 2012. https://doi.org/10.1016/j.tetlet.2012.08.119
[11] T. Nguyen, V. V. Dai, A. Mechler, L. Van Meervelt, N. T. Hoa, and Q. V.Vo, “Synthesis and computational evaluation of the antioxidant activity of pyrrolo[2,3-b]quinoxaline derivatives”, RSC advances, vol. 14, no. 34, pp. 24438-24446, 2024. DOI: 10.1039/D4RA03108C
[12] Chemboli et al., “Pyrrolo[2,3-b]quinoxalines in attenuating cytokine storm in COVID-19: their sonochemical synthesis and in silico/in vitro assessment”, Journal of Molecular Structure, 2021, vol. 1230, no. 15, pp. 129868, 2021. https://doi.org/10.1016/j.molstruc.2020.129868
[13] V. Babu et al., “Ligand/PTC-free intramolecular Heck reaction: synthesis of pyrroloquinoxalines and their evaluation against PDE4/luciferase/oral cancer cell growth in vitro and zebrafish in vivo”, Organic & Biomolecular Chemistry, vol. 11, no. 39, pp. 6680-6685, 2013. https://doi.org/10.1039/C3OB41504J
[14] K. Kolli et al., “Ligand-free Pd-catalyzed C–N cross-coupling/cyclization strategy: An unprecedented access to 1-thienyl pyrroloquinoxalines for the new approach towards apoptosis”, European Journal of Medicinal Chemistry, vol. 86, no. 30, pp. 270-278, 2014. https://doi.org/10.1016/j.ejmech.2014.08.057
[15] T. Nguyen, V. V. Dai, A. Mechler, N. T. Hoa, and Q. V. Vo, “Synthesis and evaluation of the antioxidant activity of 3-pyrroline-2-ones: experimental and theoretical insights”, RSC advances, vol. 12, no. 38, pp. 24579-24588, 2022. DOI: 10.1039/D2RA04640G
[16] A. Rashid, M. Mohammat, F. Bouchamma, Z. Shaameri, and A. Hamzah, “Facile Reduction of β-Enamino Oxopyrrolidine Carboxylates Mediated by Heterogeneous Palladium Catalyst”. Russian Journal of Organic Chemistry, vol. 56, no. 6, pp. 1082-1088, 2020. https://doi.org/10.1134/S1070428020060184
[17] G. Cook and P. M. Feltman, “Determination of Solvent Effects on Keto-Enol Equilibria of 1,3-Dicarbonyl Compounds Using NMR”, Journal of chemical education, vol. 84, no. 11, pp. 1827, 2007. https://doi.org/10.1021/ed084p1827
[18] H. McNab, “13C Nuclear Magnetic Resonance Spectra of Quinoxaline Derivatives”, Journal of the Chemical Society, Perkin Transactions 1, pp. 357-363, 1982. https://doi.org/10.1039/P19820000357

